申请人:Roche Palo Alto LLC
公开号:US20040092512A1
公开(公告)日:2004-05-13
The invention provides compound of the Formula:
1
and pharmaceutically acceptable salts or prodrugs thereof, wherein Y, Z, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, m, n, p and q are as defined herein. The invention also provides methods for preparing, compositions comprising, and methods for using Compounds of Formula I.
该发明提供了Formula:1的化合物及其药学上可接受的盐或前药,其中Y、Z、R1、R2、R3、R4、R5、R6、R7、R8、R9、m、n、p和q的定义如本文所述。该发明还提供了制备方法、包含化合物Formula I的组合物以及使用Formula I化合物的方法。